Characteristic | Number (%) |
---|---|
Age at treatment | |
Mean | 57 |
Range | 25–73 |
Concurrent systemic therapy | |
Yes | 67 (97%) |
No | 2 (3%) |
Disease subsite | |
Tonsil | 32 (46%) |
Base of tongue | 30 (43%) |
Other/multiple | 7 (10%) |
AJCC stage | |
III | 6 (9%) |
IVA | 50 (72%) |
IVB | 13 (19%) |
T stage | |
1 | 5 (7%) |
2 | 19 (28%) |
3 | 17 (25%) |
4a | 21 (30%) |
4b | 7 (10%) |
N stage | |
0 | 2 (3%) |
1 | 7 (10%) |
2a | 5 (7%) |
2b | 27 (39%) |
2c | 23 (33%) |
3 | 5 (7%) |